Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018
NCT ID: NCT04601896
Last Updated: 2021-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2020-10-16
2021-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal ECMO Flow in the Critical Phase of Cardiogenic Shock to Optimize Peripheral Organ Perfusion and Myocardial Stress
NCT06936839
Vaso-inotropic Score and ECMO-VA Support in Post-cardiotomy Cardiogenic Shock.
NCT05412303
Early Preventive Left Ventricle Unloading After VA-ECMO for Refractory Cardiogenic Shock
NCT07027202
Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation
NCT04775472
Improving Patient Reported Outcome Measures in Catheter Ablation
NCT04499326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Live patients admitted for Refractory Cardiac Arrest with ECMO
SF36 questionnaire via telephone interview
SF36 questionnaire via telephone interview
Live patients quality of life admitted for Refractory Cardiac Arrest without ECMO
SF36 questionnaire via telephone interview
SF36 questionnaire via telephone interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SF36 questionnaire via telephone interview
SF36 questionnaire via telephone interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to intensive care unit after a Refractory Cardiac Arrest
* Hemodynamic instability after resumption of spontaneous cardiac activity.
* Non-opposition of the patient or his relatives
* Admission to intensive care unit From 2006 Through 2018
Exclusion Criteria
* Comorbidity contraindicated the ECMO
* Patients dead before hospital discharge
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Grenoble Alpes
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01859-30
Identifier Type: OTHER
Identifier Source: secondary_id
38RC20.225
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.